Bio Reference Laboratories Inc Sec Registration Opko health, inc. steve rubin or adam logal, 305 575 4100. or. bio reference laboratories, inc. richard l. faherty 201 791 2600. source: opko health, inc. and bio reference laboratories, inc. news provided by acquire media. this entry was posted in press release. bookmark the permalink. Burlington, n.c. and miami, sept. 16, 2024 prnewswire labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, and opko health, inc. (nasdaq: opk), a.
Bio Reference Laboratories Inc в Logos Brands Directory In connection with this proposed business combination, bio reference laboratories and or opko will file relevant materials with the securities exchange commission (the “sec”), including an opko registration statement on form s 4, which was filed with the sec on july 2, 2015, was amended by amendment no. 1 on july 15, 2015, and was declared. Transaction to enhance labcorp's laboratory services network and expand access to the company's high quality clinical laboratory services. burlington, n.c. and miami, march 28, 2024 prnewswire labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, and opko health, inc. (nasdaq: opk), a multinational biopharmaceutical and diagnostics company, announced. Securities and exchange commission. form 10 q. of the securities exchange act of 1934. for the quarterly period ended july 31, 2006. commission file number 0 15266. bio reference laboratories, inc. 481 edward h. ross drive, elmwood park, nj 07407. (201) 791 2600. check whether the registrant (1) has filed all reports required to be filed by. In connection with this proposed business combination, bio reference laboratories and or opko will file relevant materials with the securities exchange commission (the “sec”), including an opko registration statement on form s 4 that will include a proxy statement of bio reference laboratories and constitute a prospectus of opko.
See How Bioreference Laboratories Handled A 25x Volume Spike Securities and exchange commission. form 10 q. of the securities exchange act of 1934. for the quarterly period ended july 31, 2006. commission file number 0 15266. bio reference laboratories, inc. 481 edward h. ross drive, elmwood park, nj 07407. (201) 791 2600. check whether the registrant (1) has filed all reports required to be filed by. In connection with this proposed business combination, bio reference laboratories and or opko will file relevant materials with the securities exchange commission (the “sec”), including an opko registration statement on form s 4 that will include a proxy statement of bio reference laboratories and constitute a prospectus of opko. Reference is made to the october 31, 2011 audited consolidated financial statements of bio reference laboratories, inc. contained in its annual report on form 10 k for the year ended october 31, 2011 (our “2011 form 10 k”). The acquisition includes bioreference health's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health in the united states outside of new york and new.
Comments are closed.